357 related articles for article (PubMed ID: 25579174)
1. 5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer.
Kroeze LI; van der Reijden BA; Jansen JH
Biochim Biophys Acta; 2015 Apr; 1855(2):144-54. PubMed ID: 25579174
[TBL] [Abstract][Full Text] [Related]
2. Tet family proteins and 5-hydroxymethylcytosine in development and disease.
Tan L; Shi YG
Development; 2012 Jun; 139(11):1895-902. PubMed ID: 22569552
[TBL] [Abstract][Full Text] [Related]
3. Connections between TET proteins and aberrant DNA modification in cancer.
Huang Y; Rao A
Trends Genet; 2014 Oct; 30(10):464-74. PubMed ID: 25132561
[TBL] [Abstract][Full Text] [Related]
4. Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer.
Kinney SR; Pradhan S
Adv Exp Med Biol; 2013; 754():57-79. PubMed ID: 22956496
[TBL] [Abstract][Full Text] [Related]
5. Ascorbate-induced generation of 5-hydroxymethylcytosine is unaffected by varying levels of iron and 2-oxoglutarate.
Dickson KM; Gustafson CB; Young JI; Züchner S; Wang G
Biochem Biophys Res Commun; 2013 Oct; 439(4):522-7. PubMed ID: 24021282
[TBL] [Abstract][Full Text] [Related]
6. Modulation of ten-eleven translocation 1 (TET1), Isocitrate Dehydrogenase (IDH) expression, α-Ketoglutarate (α-KG), and DNA hydroxymethylation levels by interleukin-1β in primary human chondrocytes.
Haseeb A; Makki MS; Haqqi TM
J Biol Chem; 2014 Mar; 289(10):6877-6885. PubMed ID: 24469454
[TBL] [Abstract][Full Text] [Related]
7. Characterization of acute myeloid leukemia based on levels of global hydroxymethylation.
Kroeze LI; Aslanyan MG; van Rooij A; Koorenhof-Scheele TN; Massop M; Carell T; Boezeman JB; Marie JP; Halkes CJ; de Witte T; Huls G; Suciu S; Wevers RA; van der Reijden BA; Jansen JH;
Blood; 2014 Aug; 124(7):1110-8. PubMed ID: 24986689
[TBL] [Abstract][Full Text] [Related]
8. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Lian CG; Xu Y; Ceol C; Wu F; Larson A; Dresser K; Xu W; Tan L; Hu Y; Zhan Q; Lee CW; Hu D; Lian BQ; Kleffel S; Yang Y; Neiswender J; Khorasani AJ; Fang R; Lezcano C; Duncan LM; Scolyer RA; Thompson JF; Kakavand H; Houvras Y; Zon LI; Mihm MC; Kaiser UB; Schatton T; Woda BA; Murphy GF; Shi YG
Cell; 2012 Sep; 150(6):1135-46. PubMed ID: 22980977
[TBL] [Abstract][Full Text] [Related]
9. The role of TET-mediated DNA hydroxymethylation in prostate cancer.
Smeets E; Lynch AG; Prekovic S; Van den Broeck T; Moris L; Helsen C; Joniau S; Claessens F; Massie CE
Mol Cell Endocrinol; 2018 Feb; 462(Pt A):41-55. PubMed ID: 28870782
[TBL] [Abstract][Full Text] [Related]
10. TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
Calabrese R; Valentini E; Ciccarone F; Guastafierro T; Bacalini MG; Ricigliano VA; Zampieri M; Annibali V; Mechelli R; Franceschi C; Salvetti M; Caiafa P
Biochim Biophys Acta; 2014 Jul; 1842(7):1130-6. PubMed ID: 24735979
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of ten-eleven translocation hydroxylase family proteins and 5-hydroxymethylcytosine in oligodendrocyte differentiation.
Zhao X; Dai J; Ma Y; Mi Y; Cui D; Ju G; Macklin WB; Jin W
Glia; 2014 Jun; 62(6):914-26. PubMed ID: 24615693
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond.
Guo JU; Su Y; Zhong C; Ming GL; Song H
Cell Cycle; 2011 Aug; 10(16):2662-8. PubMed ID: 21811096
[TBL] [Abstract][Full Text] [Related]
13. TET enzymes and 5hmC epigenetic mark: new key players in carcinogenesis and progression in gynecological cancers.
Zacapala-Gómez AE; Mendoza-Catalán MA; Antonio-Véjar V; Jiménez-Wences H; Ortíz-Ortíz J; Ávila-López PA; Baños-Hernández CJ; Salmerón-Bárcenas EG
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1123-1134. PubMed ID: 38375718
[TBL] [Abstract][Full Text] [Related]
14. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.
Minor EA; Court BL; Young JI; Wang G
J Biol Chem; 2013 May; 288(19):13669-74. PubMed ID: 23548903
[TBL] [Abstract][Full Text] [Related]
15. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Müller T; Gessi M; Waha A; Isselstein LJ; Luxen D; Freihoff D; Freihoff J; Becker A; Simon M; Hammes J; Denkhaus D; zur Mühlen A; Pietsch T; Waha A
Am J Pathol; 2012 Aug; 181(2):675-83. PubMed ID: 22688054
[TBL] [Abstract][Full Text] [Related]
16. Tet family of 5-methylcytosine dioxygenases in mammalian development.
Zhao H; Chen T
J Hum Genet; 2013 Jul; 58(7):421-7. PubMed ID: 23719188
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxymethylcytosine: a stable or transient DNA modification?
Hahn MA; Szabó PE; Pfeifer GP
Genomics; 2014 Nov; 104(5):314-23. PubMed ID: 25181633
[TBL] [Abstract][Full Text] [Related]
18. Loss of 5-hydroxymethylcytosine and TET2 in oral squamous cell carcinoma.
Jäwert F; Hasséus B; Kjeller G; Magnusson B; Sand L; Larsson L
Anticancer Res; 2013 Oct; 33(10):4325-8. PubMed ID: 24122999
[TBL] [Abstract][Full Text] [Related]
19. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation.
Yang H; Liu Y; Bai F; Zhang JY; Ma SH; Liu J; Xu ZD; Zhu HG; Ling ZQ; Ye D; Guan KL; Xiong Y
Oncogene; 2013 Jan; 32(5):663-9. PubMed ID: 22391558
[TBL] [Abstract][Full Text] [Related]
20. Altered global methylation and hydroxymethylation status in vulvar lichen sclerosus: further support for epigenetic mechanisms.
Gambichler T; Terras S; Kreuter A; Skrygan M
Br J Dermatol; 2014 Mar; 170(3):687-93. PubMed ID: 24164308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
